167 related articles for article (PubMed ID: 27094721)
1. Examining the efficacy of d-cycloserine to augment therapeutic learning in depression.
Otto MW; Lee J; Hofmann SG; Hearon BA; Smits JA; Rosenfield D; Fava M; Wright JH
Contemp Clin Trials; 2016 May; 48():146-52. PubMed ID: 27094721
[TBL] [Abstract][Full Text] [Related]
2. D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update.
Hofmann SG; Otto MW; Pollack MH; Smits JA
Curr Psychiatry Rep; 2015 Jan; 17(1):532. PubMed ID: 25413638
[TBL] [Abstract][Full Text] [Related]
3. D-cycloserine augmentation of cognitive behavioral therapy for delusions: A randomized clinical trial.
Diminich ED; Dickerson F; Bello I; Cather C; Kingdon D; Rakhshan Rouhakhtar PJ; Hart KL; Li C; Troxel AB; Goff DC
Schizophr Res; 2020 Aug; 222():145-152. PubMed ID: 32591238
[TBL] [Abstract][Full Text] [Related]
4. D-Cycloserine augmentation of cognitive behavior therapy for pediatric OCD: Predictors and moderators of outcome.
Wilhelm S; Berman N; Small BJ; Porth R; Storch EA; Geller D
J Affect Disord; 2018 Dec; 241():454-460. PubMed ID: 30149332
[TBL] [Abstract][Full Text] [Related]
5. Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress.
Scheeringa MS; Weems CF
J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):69-77. PubMed ID: 24506079
[TBL] [Abstract][Full Text] [Related]
6. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH
Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of the adjunct use of D-cycloserine to facilitate cognitive behavioral therapy outcomes in a cocaine-dependent population.
Kennedy AP; Gross RE; Whitfield N; Drexler KP; Kilts CD
Addict Behav; 2012 Aug; 37(8):900-7. PubMed ID: 22578380
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.
Otto MW; Tolin DF; Simon NM; Pearlson GD; Basden S; Meunier SA; Hofmann SG; Eisenmenger K; Krystal JH; Pollack MH
Biol Psychiatry; 2010 Feb; 67(4):365-70. PubMed ID: 19811776
[TBL] [Abstract][Full Text] [Related]
9. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
Goss AJ; Kaser M; Costafreda SG; Sahakian BJ; Fu CH
J Clin Psychiatry; 2013 Nov; 74(11):1101-7. PubMed ID: 24330897
[TBL] [Abstract][Full Text] [Related]
10. d-Cycloserine augmentation of cognitive remediation in schizophrenia.
Cain CK; McCue M; Bello I; Creedon T; Tang DI; Laska E; Goff DC
Schizophr Res; 2014 Mar; 153(1-3):177-83. PubMed ID: 24485587
[TBL] [Abstract][Full Text] [Related]
11. RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER.
Otto MW; Pollack MH; Dowd SM; Hofmann SG; Pearlson G; Szuhany KL; Gueorguieva R; Krystal JH; Simon NM; Tolin DF
Depress Anxiety; 2016 Aug; 33(8):737-45. PubMed ID: 27315514
[TBL] [Abstract][Full Text] [Related]
12. D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia.
Gottlieb JD; Cather C; Shanahan M; Creedon T; Macklin EA; Goff DC
Schizophr Res; 2011 Sep; 131(1-3):69-74. PubMed ID: 21723096
[TBL] [Abstract][Full Text] [Related]
13. A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.
Storch EA; Murphy TK; Goodman WK; Geffken GR; Lewin AB; Henin A; Micco JA; Sprich S; Wilhelm S; Bengtson M; Geller DA
Biol Psychiatry; 2010 Dec; 68(11):1073-6. PubMed ID: 20817153
[TBL] [Abstract][Full Text] [Related]
14. D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update.
Hofmann SG; Sawyer AT; Asnaani A
Curr Pharm Des; 2012; 18(35):5659-62. PubMed ID: 22632472
[TBL] [Abstract][Full Text] [Related]
15. Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder.
Hofmann SG; Papini S; Carpenter JK; Otto MW; Rosenfield D; Dutcher CD; Dowd S; Lewis M; Witcraft S; Pollack MH; Smits JAJ
PLoS One; 2019; 14(10):e0223729. PubMed ID: 31622374
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders.
Ori R; Amos T; Bergman H; Soares-Weiser K; Ipser JC; Stein DJ
Cochrane Database Syst Rev; 2015 May; 2015(5):CD007803. PubMed ID: 25957940
[TBL] [Abstract][Full Text] [Related]
17. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
[TBL] [Abstract][Full Text] [Related]
18. Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBT.
Lubin RE; Fitzgerald HE; Rosenfield D; Carpenter JK; Papini S; Dutcher CD; Dowd SM; Hofmann SG; Pollack MH; Smits JAJ; Otto MW
J Psychiatr Res; 2023 Aug; 164():357-363. PubMed ID: 37399757
[TBL] [Abstract][Full Text] [Related]
19. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
[TBL] [Abstract][Full Text] [Related]
20. Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.
de Kleine RA; Smits JA; Hendriks GJ; Becker ES; van Minnen A
J Anxiety Disord; 2015 Aug; 34():63-7. PubMed ID: 26121495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
